CLINICAL_TRIALS
trial_result
· 2023-04-04
Clinical Trial Update: Dexmedetomidine in Reducing Incidence of Emergence Agitation After Nasal Surgery [Phase 3]
Summary
Phase 3 trial evaluating dexmedetomidine to reduce emergence agitation after nasal surgery completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Security Forces Hospital | Conditions: Postoperative Delirium | Phase 3 | Status: COMPLETED